Literature DB >> 14552428

Classification of acute leukemias.

Richard D Brunning1.   

Abstract

Because of the increasing recognition of the importance of genetic events to the diagnosis and treatment of the acute leukemias, the proposed new World Health Organization (WHO) classification incorporates genetic aberrations and immunology as major defining features in addition to morphology. In a hierarchal approach, genetic changes have precedence in the acute myeloid leukemias and immunology and genetic changes have precedence in the acute lymphoblastic leukemias. Four major groups of acute myeloid leukemia are recognized: 1) Acute myeloid leukemias with recurrent genetic abnormalities, 2) Acute myeloid leukemia with multilineage dysplasia, 3) Acute myeloid leukemias, therapy related, and 4) Acute myeloid leukemia not otherwise categorized. Two types of acute lymphoblastic leukemia are recognized based on immunologic characteristics: precursor B lymphoblastic leukemia/lymphoma and precursor T lymphoblastic leukemia/lymphoma. Precursor B acute lymphoblastic leukemia/lymphoma is subclassified into prognostic genetic groups. Biphenotypic leukemia is recognized as a form of acute leukemia of ambiguous lineage.

Entities:  

Mesh:

Year:  2003        PMID: 14552428     DOI: 10.1016/s0740-2570(03)00031-5

Source DB:  PubMed          Journal:  Semin Diagn Pathol        ISSN: 0740-2570            Impact factor:   3.464


  3 in total

1.  Co-existence of acute myeloid leukemia with multilineage dysplasia and Epstein-Barr virus-associated T-cell lymphoproliferative disorder in a patient with rheumatoid arthritis: a case report.

Authors:  Michihide Tokuhira; Kyoko Hanzawa; Reiko Watanabe; Yasunobu Sekiguchi; Tomoe Nemoto; Yasuo Toyozumi; Jun-ichi Tamaru; Shinji Itoyama; Katsuya Suzuki; Hideto Kameda; Shigehisa Mori; Masahiro Kizaki
Journal:  J Hematol Oncol       Date:  2009-06-30       Impact factor: 17.388

2.  DNMT3A Mutations in Patients with Acute Myeloid Leukemia in South Brazil.

Authors:  Annelise Pezzi; Lauro Moraes; Vanessa Valim; Bruna Amorin; Gabriela Melchiades; Fernanda Oliveira; Maria Aparecida da Silva; Ursula Matte; Maria S Pombo-de-Oliveira; Rosane Bittencourt; Liane Daudt; Lúcia Silla
Journal:  Adv Hematol       Date:  2012-11-08

3.  High expression of ID family and IGJ genes signature as predictor of low induction treatment response and worst survival in adult Hispanic patients with B-acute lymphoblastic leukemia.

Authors:  Nataly Cruz-Rodriguez; Alba L Combita; Leonardo J Enciso; Sandra M Quijano; Paula L Pinzon; Olga C Lozano; Juan S Castillo; Li Li; Jose Bareño; Claudia Cardozo; Julio Solano; Maria V Herrera; Jennifer Cudris; Jovanny Zabaleta
Journal:  J Exp Clin Cancer Res       Date:  2016-04-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.